Biotech Values

[lreichel]

Good thoughts, I'm sure they have done the data analysis and presentation as you suggest if it is helpful to their case. One other question, what about the T cell stimulation results? Someone suggested that this is the real MOA and not the CD54 upreg.

Even if they aren't sure how it works, there appears to be evidence that Provenge has extended the lives and a significant number of patients were alive after 36 months. With supporting data of a possible benefit and no real downside, except for financial, I would think the FDA approves Provenge. Of course there is a lot of guess behind this opinion in that we don't have all the data. I have to believe the market believes otherwise, given the company's current valuation.